Why the study?
Does a palliative Mustard operation improve symptoms and hemodynamics in patients with double outlet right ventricle or transposition of the great arteries with VSD and pulmonary vascular obstructive disease?
Does a palliative Mustard operation improve symptoms and hemodynamics in patients with double outlet right ventricle or transposition of the great arteries with VSD and pulmonary vascular obstructive disease?
A palliative Mustard operation without VSD closure improves oxygenation and symptoms in selected patients with transposition of the great arteries or double outlet right ventricle complicated by pulmonary vascular obstructive disease.
May support symptom relief in select PVOD cases; hypothesis-generating and should not yet change practice.
Five patients with double outlet right ventricle, ventricular septal defect, pulmonary arterial hypertension and pulmonary vascular obstructive disease and three patients with complete d-transposition of the great arteries, ventricular septal defect, pulonary arterial hypertension and pulmonary vascular obstructive disease underwent an elective Mustard baffle operation. The ventricular septal defect was not closed. A large patent ductus arteriosus was divided in three patients. Seven of the eight patients are alive five to 32 months after surgery; one patient died 11 months after surgery. Cyanosis, dyspnea on exertion, and exercise limitation improved initially in all and has persisted in the survivors. In pre and postoperative hemodynamic studies in four patients, systemic arterial oxygen saturation and effective pulmonary blood flow increased from mean values of 70% to 90% and 1.7/min/m2 to 3.3 L/mon/m2, respectively. Absolute systemic and pulmonary flows, and pressures and resistances, were not significantly altered. Criteria for selection of patients with transposition of the great arteries of double outlet right ventricle who would benefit from a palliative Mustard procedure (Mustard atrial baffle without closure of the ventricular spetal defect) are: 1) severe symptoms; 2) pulmonary arteiral hypertension (75% systemic) with pulmonary vascular obstructive disease; and 3) pulmonary artieral oxygen saturation greater than systemic (ascending aorta) arterial oxygen saturation by approximately 10%.
No takes yet. Share an insight, caveat, or question.
Bernhard et al. (1976) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: